ASND
Price
$179.10
Change
+$3.32 (+1.89%)
Updated
Jun 24 closing price
Capitalization
10.83B
76 days until earnings call
NUVL
Price
$76.88
Change
+$0.90 (+1.18%)
Updated
Jun 24 closing price
Capitalization
5.52B
43 days until earnings call
Interact to see
Advertisement

ASND vs NUVL

Header iconASND vs NUVL Comparison
Open Charts ASND vs NUVLBanner chart's image
Ascendis Pharma A/S
Price$179.10
Change+$3.32 (+1.89%)
Volume$377.01K
Capitalization10.83B
Nuvalent
Price$76.88
Change+$0.90 (+1.18%)
Volume$624.61K
Capitalization5.52B
ASND vs NUVL Comparison Chart in %
Loading...
ASND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASND vs. NUVL commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASND is a StrongBuy and NUVL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 25, 2025
Stock price -- (ASND: $175.78 vs. NUVL: $75.98)
Brand notoriety: ASND and NUVL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASND: 63% vs. NUVL: 74%
Market capitalization -- ASND: $10.83B vs. NUVL: $5.52B
ASND [@Biotechnology] is valued at $10.83B. NUVL’s [@Biotechnology] market capitalization is $5.52B. The market cap for tickers in the [@Biotechnology] industry ranges from $308.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASND’s FA Score shows that 0 FA rating(s) are green whileNUVL’s FA Score has 0 green FA rating(s).

  • ASND’s FA Score: 0 green, 5 red.
  • NUVL’s FA Score: 0 green, 5 red.
According to our system of comparison, ASND is a better buy in the long-term than NUVL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASND’s TA Score shows that 5 TA indicator(s) are bullish while NUVL’s TA Score has 5 bullish TA indicator(s).

  • ASND’s TA Score: 5 bullish, 4 bearish.
  • NUVL’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both ASND and NUVL are a good buy in the short-term.

Price Growth

ASND (@Biotechnology) experienced а -1.09% price change this week, while NUVL (@Biotechnology) price change was -0.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.91%. For the same industry, the average monthly price growth was +35.46%, and the average quarterly price growth was +17.29%.

Reported Earning Dates

ASND is expected to report earnings on Sep 09, 2025.

NUVL is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASND($10.8B) has a higher market cap than NUVL($5.52B). ASND YTD gains are higher at: 27.682 vs. NUVL (-2.938). ASND has higher annual earnings (EBITDA): -287.37M vs. NUVL (-322.59M). NUVL has more cash in the bank: 1.07B vs. ASND (518M). ASND has higher revenues than NUVL: ASND (369M) vs NUVL (0).
ASNDNUVLASND / NUVL
Capitalization10.8B5.52B196%
EBITDA-287.37M-322.59M89%
Gain YTD27.682-2.938-942%
P/E RatioN/AN/A-
Revenue369M0-
Total Cash518M1.07B48%
Total Debt847MN/A-
FUNDAMENTALS RATINGS
ASND: Fundamental Ratings
ASND
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
76
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ASNDNUVL
RSI
ODDS (%)
Bearish Trend 3 days ago
81%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
69%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 28 days ago
71%
Bullish Trend 13 days ago
81%
Declines
ODDS (%)
Bearish Trend 8 days ago
77%
Bearish Trend 6 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 3 days ago
88%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ASND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XNTK226.842.94
+1.31%
SPDR® NYSE Technology ETF
LSGR40.260.52
+1.31%
Natixis Loomis Sayles Focused Growth ETF
HFGO23.660.23
+0.98%
Hartford Large Cap Growth ETF
MGV129.440.97
+0.76%
Vanguard Mega Cap Value ETF
THY22.240.08
+0.36%
Toews Agility Dynamic Tactical Inc ETF

ASND and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASND has been loosely correlated with NUVL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ASND jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASND
1D Price
Change %
ASND100%
-0.63%
NUVL - ASND
40%
Loosely correlated
+1.31%
ORMP - ASND
37%
Loosely correlated
-0.94%
AMRN - ASND
35%
Loosely correlated
+0.48%
AXON - ASND
34%
Loosely correlated
+0.76%
CASI - ASND
33%
Poorly correlated
-7.17%
More

NUVL and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVL has been loosely correlated with CGON. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVL jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVL
1D Price
Change %
NUVL100%
+1.31%
CGON - NUVL
55%
Loosely correlated
+0.43%
ABCZF - NUVL
51%
Loosely correlated
N/A
CRNX - NUVL
50%
Loosely correlated
-0.83%
ROIV - NUVL
50%
Loosely correlated
+0.48%
KYMR - NUVL
50%
Loosely correlated
+0.92%
More